SAMU
DMIIR

SONA Asset Management (US)’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

SONA Asset Management (US)’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44K Buy
550,000
+250,000
+83% +$21.4K ﹤0.01% 400
2026
Q1 		$24K Hold
300,000
– – ﹤0.01% 332
2025
Q4 		$42K Buy
+300,000
New +$42.8K ﹤0.01% 143

Other funds holding DMIIR

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

SONA Asset Management (US)'s DMIIR Position: Q2 2026 in Review

SONA Asset Management (US) increased its Drugs Made In America Acquisition II Corp Right (DMIIR) stake by 83% in Q2 2026, buying an estimated $21.4K and bringing the position to 550,000 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #400.

SONA Asset Management (US) first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. 61 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • SONA Asset Management (US) held 550,000 shares of Drugs Made In America Acquisition II Corp Right worth $44K as of Q2 2026.
  • SONA Asset Management (US) bought 250,000 Drugs Made In America Acquisition II Corp Right shares in Q2 2026, an estimated $21.4K.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of SONA Asset Management (US)'s portfolio in Q2 2026, its #400 holding.
  • SONA Asset Management (US) first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
  • 61 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on SONA Asset Management (US)'s 13F filing for Q2 2026, filed 14 Aug 2026.